2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Multiple Myeloma
32
Recurrence
14
Leukemia, Myeloid, Acute
14
Hodgkin Disease
12
Lymphoma
11
Neoplasms
10
Breast Neoplasms
9
Myelodysplastic Syndromes
8
Lymphoma, Non-Hodgkin
8
Lymphoma, Large B-Cell, Diffuse
8
Prostatic Neoplasms
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Leukemia
7
Carcinoma, Non-Small-Cell Lung
7
Lymphoma, T-Cell, Cutaneous
6
Sezary Syndrome
5
Neoplasms, Plasma Cell
5
Mycosis Fungoides
5
Lymphoma, Mantle-Cell
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Glioma
5
Waldenstrom Macroglobulinemia
4
Neoplasm Metastasis
4
Melanoma
4
Lymphoma, Large-Cell, Anaplastic
4
Lymphoma, Extranodal NK-T-Cell
4
Immunoblastic Lymphadenopathy
4
Diffuse Intrinsic Pontine Glioma
4
Advanced Solid Tumors
4
Primary Myelofibrosis
3
Interventions
Oxaliplatin
295
Capecitabine
209
Fluorouracil
183
Cisplatin
172
Docetaxel
140
S 1 (combination)
135
Paclitaxel
128
Leucovorin
117
Irinotecan
110
pembrolizumab
104
Trastuzumab
75
Nivolumab
59
apatinib
57
Drug Therapy
52
sintilimab
46
Surgical Procedures, Operative
45
Ramucirumab
40
Radiotherapy
40
Bevacizumab
37
Hyperthermic Intraperitoneal Chemotherapy
34
Epirubicin
32
titanium silicide
31
tislelizumab
31
Carboplatin
31
Gastrectomy
28
Cyclophosphamide
27
XELOX
25
Tegafur
24
Folfox protocol
23
Albumin-Bound Paclitaxel
23
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Panobinostat
×
Clear all
NCT01528501
2013-05-01
HDAC
Technical University of Munich
Phase 2
Terminated
28 enrolled